Tata Consultancy Services (TCS), a global leader in IT services, consulting, and business solutions, has launched TCS ADDTM AgentHub, a role-based, enterprise-ready, and trusted AI platform that enables the use of agentic AI in drug development at scale. This new agentic AI workforce transforms clinical trials and pharmacovigilance services while maintaining regulatory and audit requirements.

Pharmaceutical companies function in highly regulated environments, where they face challenges with trust, governance and scalability when applying AI across functions. Growing data volumes, fragmented systems, and increasing regulatory expectations across clinical development and pharmacovigilance are adding complexities to the entire R&D value chain.

TCS ADDTM AgentHub provides a structured framework to mitigate these challenges. Within the framework, AI agents can operate with clear roles, defined oversight, and built‑in auditability. Pharma companies can custom-build their AI agent hub and deploy it across clinical workflows. The platform allows rapid and streamlined integration with minimal effort, accelerating adoption while maintaining regulatory compliance.

Built on the TCS ADDTM framework, TCS ADDTM AgentHub delivers measurable operational benefits across drug development and drug safety functions. Solutions powered by the platform have demonstrated up to 40 per cent efficiency gains in clinical data management activities, up to 30 per cent reduction in clinical study build effort through metadata-driven automation, and up to 30 per cent cost savings in end-to-end safety case processing. AI-powered safety agents can also reduce quality control effort by as much as 50 per cent, helping organizations improve productivity across critical R&D processes.

Built on the TCS ADDTM agentic AI architecture, TCS ADDTM AgentHub enables pharma companies to deploy a Human + AI Operating Model in which AI agents are embedded into enterprise workflows, with humans retaining responsibility for governing and decision‑making.

Debashis Ghosh, President, Life Sciences and Healthcare, TCS, said, “TCS ADDTM AgentHub is a role-based, enterprise-ready, and trusted AI platform that will enable our customers to accelerate drug development using agentic AI at scale. It enables a shift from reactive to proactive, scalable, and audit-ready operations amidst an ever-changing regulatory environment. TCS’ strategy is to move towards autonomous enterprise functions where an agentic workforce operates alongside humans, driving innovation in drug development and improving patient safety.”